Heart Failure

View the latest content related to this topic

Beta-blocker Withdrawal Boosts Peak VO2 in HFpEF Subset: PRESERVE-HR

A small trial is the latest to hint that a drug common in HFpEF may not help, notably if chronotropic incompetence is present.

Shelley Wood

July 06, 2021

Slides

See all

Presentation ACC 2021

Effect of a Hospital and Post-discharge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction

Presenter: Adam DeVore

May 17, 2021

Presentation ACC 2021

Benefits of SGLT1/2 Inhibition with Sotagliflozin in Heart Failure With Preserved Ejection Fraction

Presenter: Deepak L. Bhatt

May 17, 2021

Presentation TCT 2020

Interatrial Shunting to Treat Heart Failure: Concept, Devices, and Data

Presenter: Daniel Burkhoff

October 17, 2020

Presentation TCT 2020

Acute Decompensated Heart Failure: Drugs and Devices (DRIIPPS)

Presenter: W. H. Wilson Tang

October 17, 2020

Presentation TCT 2020

Monitoring in Heart Failure: Promise and Reality

Presenter: Liviu Klein

October 17, 2020

News

See all

News Conference News HRS 2021

Heart Failure Patients With AF Benefit From Early Rhythm Control

By Shelley Wood

July 30, 2021

News Conference News HRS 2021

STROKE-VT: DOACs Cut Cerebrovascular Events After LV Arrhythmia Ablation

By Todd Neale

July 29, 2021

News Conference News TVT 2021

Optimizing Medical Therapy Before Clip Repair for MR? ‘This is Hard’

By Todd Neale

July 27, 2021

News Industry News

Affera, Inc. Announces Successful First-In-Human Use of SpherePVI Circumferential Pulmonary Vein Isolation Device Using Pulsed Field Energy

July 27, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2021

By Shelley Wood

July 21, 2021

TVT 2021

July 20

July 22, 2021

ACC 2021

May 17

May 21, 2021

HFSA 2020

September 30

October 06, 2020

Videos on This Topic

See all

Video Interview

Advertisement

Heart Failure

Beta-blocker Withdrawal Boosts Peak VO2 in HFpEF Subset: PRESERVE-HR

Slides

Effect of a Hospital and Post-discharge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction

Benefits of SGLT1/2 Inhibition with Sotagliflozin in Heart Failure With Preserved Ejection Fraction

Interatrial Shunting to Treat Heart Failure: Concept, Devices, and Data

Acute Decompensated Heart Failure: Drugs and Devices (DRIIPPS)

Monitoring in Heart Failure: Promise and Reality

News

Heart Failure Patients With AF Benefit From Early Rhythm Control

STROKE-VT: DOACs Cut Cerebrovascular Events After LV Arrhythmia Ablation

Optimizing Medical Therapy Before Clip Repair for MR? ‘This is Hard’

Affera, Inc. Announces Successful First-In-Human Use of SpherePVI Circumferential Pulmonary Vein Isolation Device Using Pulsed Field Energy

TCTMD’s Top 10 Most Popular Stories for July 2021

More on This Topic

Conference Coverage

TVT 2021

ACC 2021

HFSA 2020

Videos on This Topic

Interventional Cardiology in the Era of COVID-19

Advertisement

Heart Failure

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content